推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Signal Transduction and Targeted Therapy 期刊收藏夹

欢迎您加入月均活跃用户100万＋的科研社区！如您有任何系统建议，请点此反馈；如有合作推广需求，请点此洽谈。

按期刊名首写字母查看 SIGNAL TRANSDUC最新评论：你什么时候能不跪下呢。所谓的nature子刊不也都是一年百十来篇文章，靠新闻炒影响因子吗。怎么到了国产期刊你就看不惯了呢 (2025-05-27)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
近期推荐：
热
全流程投稿协助套餐服务
热
SCI论文AI润色+人工QC服务
新
Wiley有奖征集：科研生涯第一篇
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看：


Signal Transduction and Targeted Therapy期刊基本信息Hello，您是该期刊的第147978位访客

基本信息 登录收藏
期刊名字Signal Transduction and Targeted TherapySignal Transduction and Targeted Therapy

SIGNAL TRANSDUCT TAR
（此期刊被最新的JCR期刊SCIE收录）

LetPub评分
8.5
66人评分
我要评分

声誉
9.1

影响力
7.9

速度
9.3

期刊ISSN2095-9907
蝌蝌APP，让您与同行交流更轻松
立即下载
E-ISSN2059-3635
2024-2025最新影响因子
（数据来源于搜索引擎）		52.7 点击查看影响因子趋势图
实时影响因子 截止2025年5月19日：52.74
2024-2025自引率1.10%点击查看自引率趋势图
五年影响因子52.2
JCI期刊引文指标 5.04
h-index 暂无h-index数据
CiteScore
（ 2025年最新版）
CiteScoreSJRSNIPCiteScore排名
58.6012.1357.309
学科分区排名百分位
大类：Biochemistry, Genetics and Molecular Biology
小类：Genetics		Q11 / 348
大类：Biochemistry, Genetics and Molecular Biology
小类：Cancer Research		Q12 / 233

期刊简介
Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is a new open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, including but not limited to: cancer, cardiovascular diseases, autoimmune diseases, and nervous system diseases.
期刊官方网站http://www.nature.com/sigtrans/
期刊投稿格式模板
VIP专享
Word版格式模板  
此模板由LetPub整理，仅供参考。开通VIP可免费下载，并享1w+期刊模板资源。
 
期刊投稿网址http://mts-sigtrans.nature.com/
期刊语言要求Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Signal Transduction and Targeted Therapy的语言要求，还能让Signal Transduction and Targeted Therapy编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Signal Transduction and Targeted Therapy编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评（1篇） 论文致谢（1篇） 。
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费：需要（ GBP2590; USD3490; EUR2890; ）
文章处理费豁免：查看说明
其他费用：没有
期刊主题关键词：molecular biology、cell biology、pharmacology、medicinal chemistry、computational chemistry、systems biology
相关链接：Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
出版商Springer Nature
涉及的研究方向Biochemistry, Genetics and Molecular Biology-Genetics
出版国家或地区United Kingdom
出版语言English
出版周期
出版年份2016
年文章数 245点击查看年文章数趋势图
Gold OA文章占比100.00%
研究类文章占比：
文章 ÷（文章 + 综述）		63.67%
WOS期刊SCI分区
（ 2024-2025年最新版）		WOS分区等级：1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科：BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ11/319
学科：CELL BIOLOGYSCIEQ12/204
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科：BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ13/320
学科：CELL BIOLOGYSCIEQ16/204
中国科学院《国际期刊预警
名单（试行）》名单 		2025年03月发布的2025版：不在预警名单中

2024年02月发布的2024版：不在预警名单中

2023年01月发布的2023版：不在预警名单中

2021年12月发布的2021版：不在预警名单中

2020年12月发布的2020版：不在预警名单中
中国科学院SCI期刊分区
（ 2025年3月最新升级版） 		点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区1区2区
BIOCHEMISTRY & MOLECULAR BIOLOGY
生化与分子生物学		3区4区1区
CELL BIOLOGY
细胞生物学		1区4区1区
是否
中国科学院SCI期刊分区
（ 2023年12月升级版）
大类学科小类学科Top期刊综述期刊
医学 4区1区4区
BIOCHEMISTRY & MOLECULAR BIOLOGY
生化与分子生物学		1区3区1区
CELL BIOLOGY
细胞生物学		4区2区1区
是否
中国科学院SCI期刊分区
（ 2022年12月旧的升级版）
大类学科小类学科Top期刊综述期刊
医学 2区1区4区
BIOCHEMISTRY & MOLECULAR BIOLOGY
生化与分子生物学		2区1区1区
CELL BIOLOGY
细胞生物学		2区2区1区
是否
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
中科院的全球OA期刊索引（OAJ）
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2095-9907%5BISSN%5D
平均审稿速度网友分享经验：
5 Weeks
平均录用比例网友分享经验：
版面费/APC文章处理费信息
文章处理费：需要（ GBP2590; USD3490; EUR2890; ）
文章处理费豁免：查看说明
其他费用：没有
LetPub提供文章处理费（APC）支持服务，可以用人民币支付版面费啦！
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Signal Transduction and Targeted Therapy顺利发表。
快看看作者怎么说吧：服务好评（1篇） 论文致谢（1篇） 。
提交文稿
期刊常用信息链接
同领域相关期刊 Signal Transduction and Targeted Therapy期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Signal Transduction and Targeted Therapy中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Signal Transduction and Targeted Therapy上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    GENOME BIOLOGY19817.50
    GENOME BIOLOGY20717.50
    GENOME BIOLOGY19817.50
    Circulation-Genomic and Precision Medicine08.60
    Genes and Nutrition415.90
    Frontiers in Genome Editing09.50
    Frontiers in Aging05.10
    Microbiology Spectrum05.80
    Non-Coding RNA07.40
    Application of Clinical Genetics06.30
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE745175
    BIOMATERIALS617018
    BIOMEDICINE & PHARMACOTHERAPY610246
    Frontiers in Pharmacology577432
    COMPUTERS IN BIOLOGY AND MEDICINE575404
    JOURNAL OF ETHNOPHARMACOLOGY572391
    Frontiers in Immunology565427
    Frontiers in Oncology506532
    COLLOIDS AND SURFACES B-BIOINTERFACES472612
    PHYTOMEDICINE472171
  •  

    Signal Transduction and Targeted Therapy Signal Transduction and Targeted Therapy
    我来预测明年：
    稳步上升 表现平稳 逐渐下降　 刷新
  •  

    		  
  •  

    		  
  •  

    		  
  • 中国学者近期发表的论文
    1.Conversion of Ku80 K568 crotonylation to SUMOylation facilitates DNA non-homologous end joining and cancer radioresistance

    Author: Zhao, Hongling; Gao, Shanshan; Han, Yang; Xie, Dafei; Xuan, Lihui; Huang, Xin; Luo, Jinhua; Ran, Qian; Li, Gang; Guo, Hejiang; Hu, Weixiang; Jia, Jin; Liu, Xiaochang; Liu, Yuhao; Tan, Jinpeng; Bai, Chenjun; Gu, Yongqing; Ma, Teng; Li, Zhongjun; Guan, Hua; Huang, Ruixue; Zhou, Ping-Kun
    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2025; Vol. 10, Issue 1, pp. -. DOI: 10.1038/s41392-025-02210-1        PubMed      DOI
    2.RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer

    Author: Zha, Zhengyu; Liu, Chunxiao; Yan, Meisi; Chen, Cong; Yu, Cheng; Chen, Yaohui; Zhou, Chenhao; Li, Lu; Li, Yi-Chuan; Yamaguchi, Hiro; Ye, Leiguang; Liu, Tong; Wang, Ying-Nai; Lee, Heng-Huan; Yang, Wen-Hao; Chan, Li-Chuan; Ke, Baozhen; Hsu, Jennifer L.; Ding, Lieming; Ji, Dong; Pan, Peng; Meng, Yiran; Pu, Yue; Liu, Lunxu; Hung, Mien-Chie
    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2025; Vol. 10, Issue 1, pp. -. DOI: 10.1038/s41392-025-02206-x        PubMed      DOI
    3.Cancer chemoprevention: signaling pathways and strategic approaches

    Author: Ren, Junling; Yan, Guangli; Yang, Le; Kong, Ling; Guan, Yu; Sun, Hui; Liu, Chang; Liu, Lei; Han, Ying; Wang, Xijun
    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2025; Vol. 10, Issue 1, pp. -. DOI: 10.1038/s41392-025-02167-1        PubMed      DOI
    4.Deep insight into cytokine storm: from pathogenesis to treatment

    Author: Nie, Jiali; Zhou, Ling; Tian, Weiwei; Liu, Xiansheng; Yang, Liping; Yang, Xingcheng; Zhang, Yicheng; Wei, Shuang; Wang, Dao Wen; Wei, Jia
    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2025; Vol. 10, Issue 1, pp. -. DOI: 10.1038/s41392-025-02178-y        PubMed      DOI
    5.Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trial

    Author: Bian, Huijie; Chen, Liang; Zhang, Zheng; Wen, Ai-Dong; Zheng, Zhao-Hui; Song, Li-Qiang; Yao, Meng-Ying; Liu, Ying-Xia; Zhang, Xi-Jing; Dong, Hong-Lin; Lian, Jian-Qi; Pan, Lei; Liu, Yu; Gu, Xing; Zhao, Hui; Wang, Jing-Wen; Wang, Qing-Yi; Zhang, Kui; Jia, Jun-Feng; Xie, Rong-Hua; Luo, Xing; Fu, Xiang-Hui; Jia, Yan-Yan; Hou, Jun-Na; Tan, Qiu-Yue; Chen, Xiao-Xia; Yang, Liu-Qing; Lin, Yuan-Long; Wang, Xiao-Xia; Zhang, Lei; Zeng, Qin-Jing; Li, Wen-Jie; Wang, Rui-Xuan; Zhang, Yang; Sun, Xiu-Xuan; Wang, Bin; Yang, Xu; Jiang, Jian-Li; Li, Ling; Wu, Jiao; Yang, Xiang-Min; Zhang, Hai; Shi, Ying; Chen, Xiao-Chun; Tang, Hao; Shi, Hong-Wei; Liu, Shuang-Shuang; Yang, Yong; Yang, Tian-Yi; Wei, Ding; Chen, Zhi-Nan; Zhu, Ping
    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2025; Vol. 10, Issue 1, pp. -. DOI: 10.1038/s41392-025-02208-9        PubMed      DOI
    6.Novel derivatives of brincidofovir and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine inhibit orthopoxviruses and human adenoviruses more potently than brincidofovir

    Author: Zhang, Yifan; Wan, Yanmin; Guo, Cuiyuan; Zhu, Zhaoqin; Qiu, Chao; Lu, Jiasheng; Zhou, Yanan; Zheng, Jiaojiao; Dai, Fahui; Cheng, Xiaoyang; Deng, Kunlu; Wang, Wanhai; Wang, Youchun; Zhang, Wenhong
    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2025; Vol. 10, Issue 1, pp. -. DOI: 10.1038/s41392-025-02207-w        PubMed      DOI
    7.Tripeptide DT-109 (Gly-Gly-Leu) attenuates atherosclerosis and vascular calcification in nonhuman primates

    Author: Jia, Linying; Qu, Pengxiang; Zhao, Yang; Bai, Liang; Ren, Honghao; Cheng, Ao; Ma, Zeyao; Ding, Cheng; Deng, Yongjie; Kong, Lingxuan; Zhao, Ying; Rom, Oren; Chen, Yajie; Alam, Naqash; Cao, Wenbin; Zhai, Sixue; Zheng, Zuowen; Hu, Zhi; Wang, Lu; Chen, Yabing; Zhao, Sihai; Zhang, Jifeng; Fan, Jianglin; Chen, Y. Eugene; Liu, Enqi
    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2025; Vol. 10, Issue 1, pp. -. DOI: 10.1038/s41392-025-02201-2        PubMed      DOI
    8.Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances

    Author: Xue, Chen; Chu, Qingfei; Shi, Qingmiao; Zeng, Yifan; Lu, Juan; Li, Lanjuan
    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2025; Vol. 10, Issue 1, pp. -. DOI: 10.1038/s41392-025-02142-w        PubMed      DOI
    9.Chronic mild stress exacerbates atrial fibrillation and neutrophil extracellular traps formation through S100A8/A9 signaling

    Author: Meng, Shan; Huang, Tao; Zhou, Zijun; Yu, Liming; Wang, Huishan
    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2025; Vol. 10, Issue 1, pp. -. DOI: 10.1038/s41392-025-02199-7        PubMed      DOI
    10.C/EBPβ activation in vascular smooth muscle cells promotes hyperlipidemia-induced phenotypic transition and arterial stiffness

    Author: Ma, Jun; Yang, Xiangyu; Li, Yanan; Zhang, Xin; Liu, Kai; Peng, Yong; Wang, Si; Shi, Rufeng; Huo, Xingwei; Liu, Xueting; Li, Xinran; Ye, Runyu; Zhang, Zhipeng; Yang, Changqiang; Liu, Lu; Gao, Dan; Jia, Shanshan; Sun, Lirong; Zuo, Xianghao; Meng, Qingtao; Chen, Xiaoping
    Journal: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2025; Vol. 10, Issue 1, pp. -. DOI: 10.1038/s41392-025-02196-w        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    NATURE REVIEWS DRUG DISCOVERY289181.80
    Kidney International Supplements2046.20
    Kidney International Supplements2446.20
    LANCET70087.60
    Nature Reviews Clinical Oncology127114.50
    NEW ENGLAND JOURNAL OF MEDICINE93396.40
    NATURE REVIEWS CANCER396103.80
    World Psychiatry6174.00
    World Psychiatry7074.00
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS1441154.20
    NATURE REVIEWS MICROBIOLOGY250106.40
    NATURE REVIEWS DRUG DISCOVERY289181.80
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386150.90
    LANCET70087.60
    Nature Reviews Materials61105.50
    Nature Reviews Clinical Oncology127114.50
    NEW ENGLAND JOURNAL OF MEDICINE93396.40
    Nature Reviews Earth & Environment070.00
    NATURE REVIEWS CANCER396103.80
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分：

同领域作者分享投稿经验：共11条


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2025 中国: LetPub上海    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）

    增值电信业务经营许可证：沪B2-20211595    网络文化经营许可证：沪网文[2023]2004-152号

    礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室